Friday 6 November 2026
Export CHE’s income statement to Excel — free account
Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
525.70
8.07
−1.51%
Follow CHE
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 5 | 5 | 7 |
| 25.28% | 25.60% | 27.11% | 29.14% | ||
| 16.54% | 15.93% | 16.68% | 16.90% | ||
ROIC |
23.36% | 22.23% | 23.46% | 22.10% | |
Return on Tangible Assets |
119.94% | 161.98% | 152.87% | 112.17% | |
Average Days of Receivables |
26.34 | 30.96 | 26.53 | 34.96 | |
Free Cash Flow per Share |
22.92 | 27.91 | 24.91 | 22.73 | |
Free Cash Flow |
330.05 | 381.71 | 328.12 | 296.76 | |
Capital Expenditures |
(58.23) | (62.04) | (61.84) | (66.40) | |
| Other line items | |||||
Cash ROIC |
31.32% | 39.93% | 32.46% | 25.90% | |
Accounts Receivable Turnover |
14.30 | 10.13 | 13.90 | 11.31 | |
Accounts Payable Turnover |
31.43 | 30.30 | 25.60 | 31.19 | |
Inventory Turnover |
216.93 | 229.10 | 206.90 | 221.26 | |
Average Days of Payables |
13.78 | 13.96 | 17.81 | 13.48 | |
Days of Inventory on Hand |
1.61 | 1.53 | 1.60 | 1.60 | |
Tax Rate |
(0.25) | (0.26) | (0.26) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.49% | 16.76% | 16.99% | 16.78% | |
Share Based Compensation of Revenue |
1.48% | 1.44% | 1.46% | 1.55% | |
Interest Coverage |
193.28 | 169.72 | 106.49 | 75.39 | |
Operating CF/Net income |
1.46 | 1.71 | 1.42 | 1.29 | |
Depreciation/Fixed assets |
0.32 | 0.32 | 0.32 | 0.31 | |
Capex/Depreciation |
(0.89) | (0.94) | (0.93) | (0.98) | |
Revenue per Share |
175.72 | 185.78 | 196.98 | 203.79 | |
Operating CF per Share |
26.97 | 32.45 | 29.60 | 27.81 | |
Capex per Share |
(4.04) | (4.54) | (4.69) | (5.08) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026